Erasca, Inc. Common Stock (ERAS) Stock
Key stats
- Market cap
- $5.88B
- Price / Earnings ratio
- -18.9x
- EPS (TTM)
- -$0.95
- Volume
- Loading
- 52-week high
- $24.28
- 52-week low
- $2.21
Source: third-party data provider, as of November 13, 2026
Compare with ERAS
Recent news

ERAS Investors with $100,000 in Losses Have Opportunity to Join Erasca, Inc. Fraud Investigation with SBS Law
ERAS Investors with $100,000 in Losses Have Opportunity to Join Erasca, Inc. Fraud Investigation with SBS Law
ERAS

ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with SBS Law
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with SBS Law
ERAS

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
ERAS

Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc. - ERAS
Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc. - ERAS
ERAS
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 61.51
- MACD 12/26/9
- 0.13
- EMA 9 of MACD
- -0.11
- MACD histogram
- 0.24
- SMA 50
- $14.98
- Price above SMA 50
- EMA 50
- $15.23
- Price above EMA 50
- SMA 200
- $15.20
- Price above SMA 200
- EMA 200
- $13.52
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

ERAS Investors with $100,000 in Losses Have Opportunity to Join Erasca, Inc. Fraud Investigation with SBS Law
ERAS Investors with $100,000 in Losses Have Opportunity to Join Erasca, Inc. Fraud Investigation with SBS Law
ERAS

ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with SBS Law
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with SBS Law
ERAS

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
ERAS

Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc. - ERAS
Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc. - ERAS
ERAS

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights
Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights
ERAS

ERAS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Erasca, Inc. Securities Lawsuit - Contact Levi & Korsinsky
ERAS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Erasca, Inc. Securities Lawsuit - Contact Levi & Korsinsky
ERAS

ERAS INVESTOR REMINDER: Erasca, Inc. Investors Have Until August 10, 2026 to Seek Lead Plaintiff Role
ERAS INVESTOR REMINDER: Erasca, Inc. Investors Have Until August 10, 2026 to Seek Lead Plaintiff Role
ERAS

Law Offices of Frank R. Cruz Encourages Erasca, Inc. (ERAS) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Frank R. Cruz Encourages Erasca, Inc. (ERAS) Shareholders To Inquire About Securities Fraud Class Action
ERAS

Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
ERAS

Deadline Approaching: Erasca, Inc. (ERAS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Deadline Approaching: Erasca, Inc. (ERAS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
ERAS
News tone: automated (AI) classification of the article's content, not a price prediction.
About Erasca, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Jonathan E. Lim M.D. | Co-Founder, Chairman & CEO | 1972 |
| Dr. Michael D. Varney Ph.D. | Chairman of Research & Development, Scientific Advisory Board Member and Director | 1958 |
| Dr. David M. Chacko M.D. | CFO & Chief Business Officer | 1983 |
| Dr. Nik Chetwyn Ph.D. | Chief Operating Officer | — |
| Dr. Shannon R. Morris M.D., Ph.D. | Chief Medical Officer | 1970 |
| Ms. Alison Tjosvold Milhous | Senior Vice President of Accounting | 1979 |
| Dr. Robert Shoemaker Ph.D. | Chief Scientific Officer | 1981 |
| Mr. Ebun S. Garner Esq., J.D. | Chief Legal Officer & Corporate Secretary | 1972 |
| Dr. Lisa Tesvich-Bonora Ph.D. | Chief People Officer | — |
| Mr. Brian L. Baker CPA, M.S. | Senior Vice President of Finance | 1967 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 61.51
- MACD 12/26/9
- 0.13
- EMA 9 of MACD
- -0.11
- MACD histogram
- 0.24
- SMA 50
- $14.98
- Price above SMA 50
- EMA 50
- $15.23
- Price above EMA 50
- SMA 200
- $15.20
- Price above SMA 200
- EMA 200
- $13.52
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $20.00
- Average
- $20.00
- High
- $20.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -25.3 | +9.6 | ||||||||||
| 2022 | -23.4 | +7.5 | -29.0 | -13.8 | -31.5 | +11.0 | +29.6 | +25.3 | -10.0 | +1.0 | -5.7 | -41.3 |
| 2023 | -6.1 | -10.0 | -14.0 | -12.4 | -3.9 | +2.6 | -4.3 | -2.3 | -23.9 | +19.7 | -25.1 | +27.5 |
| 2024 | -23.0 | +38.4 | -19.2 | -6.9 | +20.6 | -8.5 | +29.1 | -5.9 | -0.4 | +0.0 | +5.1 | -22.3 |
| 2025 | -30.0 | -22.2 | +7.0 | +20.7 | -6.0 | -11.2 | +4.4 | +12.9 | +36.3 | +9.5 | +33.2 | +24.0 |
| 2026 | +192.8 | +28.7 | +11.4 | -35.8 | +28.0 | +32.6 | +1.3 | +0.2 | -12.5 | -1.6 | +19.6 |



